Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consistent loss of chromosome 4

European Journal of Cancer

Volumn 33, Issue 10, 1997, Pages 1677-1684

  Wu, M C ^a   Sundaresan, M ^b   Sundaresan, V ^a   Rabbitts, P ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chromosome paint; Lung adenocarcinoma; Mouse chromosome 4; Mouse model; P53 transgenic mice

Indexed keywords

PROTEIN P53; VALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME DELETION 4; CHROMOSOME LOSS; CHROMOSOME PAINTING; CONTROLLED STUDY; GENETIC DISORDER; GENOME; KARYOTYPE; LUNG ADENOCARCINOMA; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; ROBERTSONIAN CHROMOSOME TRANSLOCATION; TETRAPLOIDY; TRANSGENE; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; CHROMOSOME ABERRATIONS; DISEASE MODELS, ANIMAL; GENES, P53; GENOME; KARYOTYPING; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; TUMOR CELLS, CULTURED;

EID: 0031418449     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00162-7     Document Type: Article

References (30)

1. Testa JR, Siegfried JM, Liu Z, et al Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosome Cancer 1994, 11, 178-194.
2. Sato S, Nakamura Y, Tsuchiya E Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1994, 54, 5652-5655.
3. Tsuchiya E, Nakamura Y, Weng S, et al Allelotype of non-small cell lung carcinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 1992, 52, 2478-2481.
4. Fong KM, Kida Y, Zimmerman PV, Ikenaga M, Smith PJ Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res 1995, 55, 4268-4272.
5. Fujino M, Dosaka-Akita H, Harada M, et al Prognostic significance of p53 and ras p21 expression in non-small cell lung cancer. Cancer 1995, 76, 2457-2463.
6. Slebos RJC, Kibbelaar RE, Dalesio O, et al K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990, 323, 561-565.
7. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368, 753-756.
8. INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 1995, 55, 6200-6209.
9. Malkinson AM Primary lung tumours in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res (suppl) 1992, 52, 2670s-2676s.
10. Hegi ME, Soderkvist P, Foley JF, et al Characterization of p53 mutations in methylene chloride-induced lung tumours from B6C3F1 mice. Carcinogenesis 1993, 14, 803-810.
11. Goodrow TL, Storer RD, Leander KR, Prahalada SR, van Zwieten MJ, Bradley MO Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumours. Mol Carcinog 1992, 5, 9-15.
12. Fijneman RJA, Ophoff RA, Hart AAM, Demant P Kras-2 alleles, mutations, and lung tumour susceptibility in the mouse - an evaluation. Oncogene 1994, 9, 1417-1421.
13. Re FC, Manenti G, Borrello MG, et al Multiple molecular alterations in mouse lung tumours. Mol Carcinog 1992, 5, 155-160.
14. Wiseman RW, Cochran C, Deitrich W, Lancer ES, Soderkvist P Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumour-suppressor genes. Proc Natl Acad Sci USA 1994, 91, 3759-3763.
15. Herzog CR, Wiseman RW, You M Deletion mapping of a putative tumour suppressor gene on chromosome 4 in mouse lung tumours. Cancer Res 1994, 54, 4007-4010.
16. Hegi ME, Devereux TR, Dietrich WF, et al Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 1994, 54, 6257-6264.
17. Herzog CR, Wang Y, You M Allelic loss of distal chromosome 4 in mouse lung tumours localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene 1995, 11, 1811-1815.
18. Malkinson AM The genetic basis of susceptibility to lung tumours in mice. Toxicology 1989, 54, 241-271.
19. Sandgren EP, Quaife CJ, Pinken CA, Palmiter RD, Brinster RL Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989, 4, 715-724.
20. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A High incidence of lung, bone, and lymphoid tumours in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989, 9, 3982-3991.
21. Tsukada T, Tomooka Y, Takai S, et al. Ehanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 1992, 8, 3313-3322.
22. Rabbitts P, Impey H, Heppell-Parton A, et al Chromosome specific paints from a high resolution flow karyotype of the mouse. Nature Genet 1995, 9, 369-375.
23. Heppell-Parton AC, Albertson DG, Fishpool R, Rabbitts PH Multicolour flurorescence in situ hybridisation to order small, single-copy probes on metaphase chromosomes. Cytogenet Cell Genet 1994, 66, 42-47.
24. ISCN (1995). An International System for Human Cytogenetic Nomenclature. Mitelman F, ed. Basel, S. Karger.
25. Sundaresan V, Ganly P, Hasleton P, et al p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in pre-invasive lesions of the bronchus. Oncogene 1992, 7, 1989-1997.
26. Chung GTY, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH Clonal evolution of lung tumors. Cancer Res 1996, 56, 1609-1614.
27. Dipaolo JA Chromosome patterns in mouse lung tumours. J Natl Cancer Inst 1965, 34, 337-343.
28. Marcus I, Smith GJ Cytogenetic profile of in vitro spontaneously transformed and chemical tumour-derived cell lines related to the mouse lung alveologenic carcinoma. Cancer Res 1990, 50, 164-168.
29. Noguchi H, Morikawa A, Kawasaki M, et al Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75, 2844-2852.
30. Belinski SA, Stefanski SA, Anderson MW The A/J mouse lung as a model for developing new chemointervention strategies. Cancer Res 1993, 53, 410-416.